Top Institutions in Ophthalmology - Retinal Diseases and Gene Therapy
Leading institutions in retinal gene therapy and wet AMD clinical trials utilize advanced intravitreal delivery systems, molecular biology expertise in AAV vectors, and conduct multi-phase clinical trials assessing efficacy and safety of novel gene therapies.
-
#1
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is a world leader in retinal disease research and gene therapy clinical trials, with extensive experience in wet AMD and intravitreal treatment modalities.
Key Differentiators
- Ophthalmology
- Retinal Diseases
- Gene Therapy
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Known for cutting-edge research in retinal gene therapy and leadership in clinical trials targeting neovascular AMD and other retinal disorders.
Key Differentiators
- Ophthalmology
- Retinal Diseases
- Gene Therapy
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a strong track record in retinal disease management and gene therapy research, contributing to advancements in treatment of wet AMD.
Key Differentiators
- Ophthalmology
- Retinal Diseases
- Gene Therapy
-
#4
Retina Macula Institute of Arizona
Phoenix, AZ
Actively involved in the PRISM trial and early clinical development of 4D-150 gene therapy for wet AMD, demonstrating leadership in innovative retinal treatments.
Key Differentiators
- Ophthalmology
- Retinal Diseases
- Clinical Research
-
#5
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is a leader in retinal disease research and gene therapy clinical trials, with strong translational programs targeting neovascular AMD.
Key Differentiators
- Ophthalmology
- Retinal Diseases
- Gene Therapy
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







